[논문]Mesoporous silica nanoparticles as a promising skin delivery system for methotrexate

Sapino, Simona; Oliaro-Bosso, Simonetta; Zonari, Daniele; Zattoni, Andrea; Ugazio, Elena

doi:10.1016/j.ijpharm.2017.07.058

Mesoporous silica nanoparticles as a promising skin delivery system for methotrexate 원문보기

International journal of pharmaceutics, v.530 no.1/2, 2017년, pp.239 - 248

Sapino, Simona (Università) , Oliaro-Bosso, Simonetta (di Torino, Dipartimento di Scienza e Tecnologia del Farmaco, Via P. Giuria 9, 10125 Turin, Italy) , Zonari, Daniele (Università) , Zattoni, Andrea (di Torino, Dipartimento di Scienza e Tecnologia del Farmaco, Via P. Giuria 9, 10125 Turin, Italy) , Ugazio, Elena (Università)

Abstract ▼ AI-Helper

Abstract The systemic administration of methotrexate (MTX), a commonly used, antineoplastic drug which is also used in cutaneous disorders, is primarily associated with prolonged retention in the body and consequently with side effects. Innovative drug delivery techniques and alternative administration routes would therefore contribute to its safe and effective use. The general objective of this study is thus the development of MTX-based preparations for the topical treatment of skin disorders. MCM-41-like nanoparticles (MSN), are herein proposed as carriers which can improve the cutaneous absorption and hence the bioavailability and efficacy of MTX. The MTX/MSN complex, prepared via the impregnation procedure, has been physico-chemically characterized, while its cell cultures have had their biocompatibility and bioactivity tested. Furthermore, a series of stable MTX-based dermal formulations has been developed, some containing shea butter, a natural fat. Ex-vivo porcine skin absorption and the transepidermal permeation of MTX have also been monitored in a variety of media using Franz diffusion cells. Interestingly, the epidermal accumulation of the active molecule was increased by its inclusion into MSN, regardless of the surrounding medium. Furthermore, the presence of shea butter enhanced the skin uptake of the drug both in the free and in the loaded form. Highlights Innovative MCM-41-based nanocarrier for cutaneous MTX application. Biocompatibility assessed in keratinocyte HaCaT cells. Skin uptake favored by the presence of shea butter in dermal formulations. SEM observations confirmed MSN accumulation in the epidermis. Graphical abstract [DISPLAY OMISSION]

주제어

참고문헌 (27)

Eur. J. Pharm. Sci. Abbaszad Rafi 93 64 2016 10.1016/j.ejps.2016.08.005

상세보기
Colloids Surf. B: Biointerfaces Alexa 106 135 2013 10.1016/j.colsurfb.2013.01.022 A comparative study on long-term MTX controlled release from intercalated nanocomposites for nanomedicine applications

상세보기
Int. J. Pharm. Alvarez-Figueroa 215 57 2001 10.1016/S0378-5173(00)00674-8 Transdermal delivery of methotrexate: iontophoretic delivery from hydrogels and passive delivery from microemulsions

상세보기
Pharmazie Boonen 66 463 2011 Skin penetration of silica microparticles

상세보기
Expert Rev. Clin. Immunol. Cipriani 10 1519 2014 10.1586/1744666X.2014.962996 Methotrexate: an old new drug in autoimmune disease

상세보기
Clin. Ther. Cipriani 36 427 2014 10.1016/j.clinthera.2014.01.014 Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. current and emerging paradigms

상세보기
J. Rheumatol. Curtis 43 1997 2016 10.3899/jrheum.151212 Adherence and persistence with methotrexate in rheumatoid arthritis: a systematic review

상세보기
Clin. Chim. Acta Elango 451 329 2015 10.1016/j.cca.2015.10.020 Methotrexate normalized keratinocyte activation cycle by overturning abnormal keratins as well as deregulated inflammatory mediators in psoriatic patients

상세보기
Colloids Surf. B: Biointerfaces Garg 147 17 2016 10.1016/j.colsurfb.2016.07.046 Effective transdermal delivery of methotrexate through nanostructured lipid carriers in an experimentally induced arthritis model

상세보기
J. Microsc. Goldstein 256 237 2014 10.1111/jmi.12179 High resolution SEM imaging of gold nanoparticles in cells and tissues

상세보기
Inflamm. Bowel Dis. Herfarth 22 224 2016 10.1097/MIB.0000000000000589 Use of methotrexate in the treatment of inflammatory bowel diseases

상세보기
BBA Clin. Hess 3 152 2015 10.1016/j.bbacli.2015.01.006 Cancer metabolism and oxidative stress: insights into carcinogenesis and chemotherapy via the non-dihydrofolate reductase effects of methotrexate

상세보기
Colloids Surf. B: Biointerfaces Javadzadeh 82 422 2011 10.1016/j.colsurfb.2010.09.015 Enhancing percutaneous delivery of methotrexate using different types of surfactants

상세보기
Leukemia Res. Kim 36 350 2012 10.1016/j.leukres.2011.07.027 A combination of methotrexate and irradiation promotes cell death in NK/T-cell lymphoma cells via down-regulation of NF-κB signaling

상세보기
J. Innov. Opt. Health Sci. Lademann 8 1530004 2015 10.1142/S1793545815300049 Hair follicles as a target structure for nanoparticles

상세보기
Semin. Arthritis Rheum. Li 45 656 2016 10.1016/j.semarthrit.2015.11.004 Subcutaneous administration of methotrexate at high doses makes a better performance in the treatment of rheumatoid arthritis compared with oral administration of methotrexate: a systematic review and meta-analysis

상세보기
Eur. J. Pharm. Sci. Muhammad 91 251 2016 10.1016/j.ejps.2016.04.029 PEG capped methotrexate silver nanoparticles for efficient anticancer activity and biocompatibility

상세보기
Int. J. Cancer Pan 139 1864 2016 10.1002/ijc.30214 Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: a prospective and single-arm study

상세보기
Int. J. Pharm. Peruzynska 506 458 2016 10.1016/j.ijpharm.2016.03.041 In vitro and in vivo evaluation of sandwich-like mesoporous silica nanoflakes as promising anticancer drug delivery system

상세보기
J. Eur. Acad. Dermatol. Venereol. Quist 30 1537 2016 10.1111/jdv.13656 Pharmacokinetic profile of methotrexate in psoriatic skin via the oral or subcutaneous route using dermal microdialysis showing higher methotrexate bioavailability in psoriasis plaques than in non-lesional skin

상세보기
Trends Biotechnol. Reschiglian 23 475 2005 10.1016/j.tibtech.2005.07.008 Field-flow fractionation and biotechnology

상세보기
Eur. J. Pharm. Biopharm. Sapino 89 116 2015 10.1016/j.ejpb.2014.11.022 Mesoporous silica as topical nanocarriers for quercetin: characterization and in vitro studies

상세보기
J. Pharm. Sci. Sekkat 91 2376 2002 10.1002/jps.10220 Biophysical study of porcine ear skin in vitro and its comparison to human skin in vivo

상세보기
Int. J. Pharm. Ugazio 511 446 2016 10.1016/j.ijpharm.2016.07.024 Thermoresponsive mesoporous silica nanoparticles as a carrier for skin delivery of quercetin

상세보기
Angew. Chem. Int. Ed. Vallet-Regi 46 7548 2007 10.1002/anie.200604488 2007 Mesoporous materials for drug delivery

상세보기
Expert Rev. Clin. Immunol. Yelamos 11 553 2015 10.1586/1744666X.2015.1026894 Systemic methotrexate for the treatment of psoriasis

상세보기
Dermatology Yelamos 229 306 2014 10.1159/000366501 Acute severe methotrexate toxicity in patients with psoriasis: a case series and discussion

상세보기

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

Mesoporous silica nanoparticles as a promising skin delivery system for methotrexate 원문보기

Abstract ▼ AI-Helper

주제어

참고문헌 (27)

이 논문을 인용한 문헌

관련 콘텐츠

원문 보기

원문 URL 링크

오픈액세스(OA) 유형

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트